Nexium (Esomeprazole Magnesium Trihydrate)

Nexium, a proton pump inhibitor, acts on the gastric acid‑secreting pathway to treat several acid‑related disorders.

• Gastro‑oesophageal reflux disease (GERD): relieves heartburn and promotes healing of the esophageal lining.
• Erosive oesophagitis: reduces acid exposure to allow ulcerated tissue to heal.
• Prevention of NSAID‑induced gastric ulcers: protects the stomach lining in patients taking non‑steroidal anti‑inflammatory drugs.
• Zollinger‑Ellison syndrome: controls excessive gastric acid secretion caused by gastrin‑producing tumors.
• Helicobacter pylori eradication (in combination therapy): enhances the effectiveness of antibiotic regimens by lowering stomach acidity.

• Esomeprazole magnesium trihydrate irreversibly binds to the H+/K+ ATPase enzyme (the gastric proton pump) on the parietal cell membrane, blocking the final step of acid secretion. By inhibiting this pump, the drug markedly reduces both basal and stimulated gastric acid output, creating a less acidic gastric environment that facilitates healing of acid‑related lesions.

Common Side Effects

• Headache: mild to moderate pain often occurring early in therapy.
• Diarrhea: loose stools that may resolve with continued use.
• Nausea: feeling of stomach upset or queasiness.
• Abdominal pain: discomfort or cramping in the stomach area.
• Flatulence: increased gas production.
• Constipation: difficulty passing stools.

Serious or Rare Side Effects

• Clostridioides difficile infection: severe colitis presenting with watery diarrhea.
• Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing.
• Elevated liver enzymes: signs of hepatic stress detectable in blood tests.
• Hypomagnesemia: low magnesium levels causing muscle cramps or arrhythmias.
• Stevens‑Johnson syndrome: rare skin blistering disorder.
• Bone fracture risk: potential reduction in calcium absorption with long‑term use.

Before initiating therapy, consider the following precautions:

• Assess renal function: adjust use in patients with severe impairment.
• Monitor for infection: be alert to symptoms of C. difficile colitis.
• Review duration of therapy: avoid unnecessary long‑term use without reassessment.
• Evaluate concomitant medications: check for potential drug‑drug interactions.
• Store at room temperature: keep in the original pack, protect from moisture.

Esomeprazole may interact with several medicines, requiring careful management.

Major Interactions (Avoid)

• Clopidogrel: reduced antiplatelet effectiveness.
• Atazanavir: decreased absorption leading to sub‑therapeutic levels.
• Warfarin: possible increase in INR and bleeding risk.

Moderate Interactions (Monitor Closely)

• Diazepam: increased serum concentrations.
• Methotrexate: reduced renal clearance and potential toxicity.
• Digoxin: elevated plasma levels increasing risk of toxicity.